Comparative Pharmacology
Head-to-head clinical analysis: HYDROMOX versus NATURETIN 2 5.
Head-to-head clinical analysis: HYDROMOX versus NATURETIN 2 5.
HYDROMOX vs NATURETIN-2.5
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits the sodium-chloride symporter (NCC) in the distal convoluted tubule of the kidney, reducing sodium and chloride reabsorption and increasing water excretion.
Bendroflumethiazide is a thiazide diuretic that inhibits the sodium-chloride symporter (NCC) in the distal convoluted tubule of the kidney, reducing sodium and chloride reabsorption and promoting diuresis.
50-100 mg orally once daily; may increase to 200 mg/day for severe edema.
Hypertension: 2.5 mg orally once daily; may increase to 5 mg daily if needed. Edema: 2.5 to 10 mg orally once daily.
None Documented
None Documented
Terminal elimination half-life: 6-9 hours; prolonged to 24-36 hours in renal impairment (CrCl <30 mL/min)
Terminal elimination half-life: 6-9 hours; prolonged in renal impairment and in elderly patients.
Renal: 70% unchanged via tubular secretion; biliary/fecal: <10%
Renal excretion: approximately 95% as unchanged drug; biliary/fecal: <5%.
Category C
Category C
Thiazide Diuretic
Thiazide Diuretic